ADC Therapeutics SA
ADC Therapeutics SA
ADC Therapeutics SA (ADCT) — SEC Financial Statements & Analysis
ADC Therapeutics SA (ADCT) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||
Assets Current | |||||||||||||||
Cash And Cash Equivalents At Carrying Value | 231 | 261 | 235 | 265 | 195 | 251 | 274 | 300 | 234 | 279 | |||||
Accounts And Other Receivables Net Current | 31 | 29 | 23 | 26 | 32 | 20 | 24 | 23 | 23 | 25 | |||||
Inventory Net | 5 | 4 | 18 | 18 | 17 | 2 | 16 | 15 | 16 | 16 | |||||
Prepaid Expense And Other Assets Current | 6 | 6 | 6 | 5 | 7 | 8 | 19 | 17 | 17 | 10 | |||||
Other Assets Current | 4 | 6 | 6 | 6 | 7 | 9 | - | - | - | 6 | |||||
Assets Current | 277 | 306 | 287 | 319 | 258 | 291 | 333 | 355 | 290 | 336 | |||||
Inventory Noncurrent | 12 | 14 | - | - | - | 16 | - | - | - | - | |||||
Property Plant And Equipment Net | - | 0 | 0 | 0 | 5 | 5 | 6 | 5 | 6 | 6 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 8 | 8 | 9 | 10 | 10 | 11 | |||||
Equity Method Investments | - | - | - | - | - | 0 | 0 | 0 | 1 | 2 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | 0 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 291 | 323 | 290 | 322 | 273 | 322 | 349 | 372 | 308 | 355 | |||||
Liabilities And Stockhold… | |||||||||||||||
Liabilities Current | |||||||||||||||
Accounts Payable Current | 5 | 9 | 8 | 10 | 16 | 18 | 14 | 11 | 14 | 16 | |||||
Accrued Liabilities Current | 58 | 58 | 54 | 55 | 42 | 62 | 53 | 47 | 49 | 52 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | 1 | |||||
Long Term Debt Current | 5 | 3 | - | - | - | 0 | - | - | - | - | |||||
Liabilities Current | 68 | 70 | 62 | 65 | 58 | 80 | 68 | 58 | 63 | 68 | |||||
Secured Long Term Debt | 111 | 112 | 115 | 114 | 114 | 114 | 114 | 114 | 113 | 113 | |||||
Warrants And Rights Outstanding | 19 | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 8 | 8 | 9 | 9 | 10 | 10 | |||||
Other Liabilities Noncurrent | 5 | 3 | 9 | 7 | 4 | 2 | 8 | 7 | 7 | 9 | |||||
Liabilities | 508 | 509 | 528 | 521 | 511 | 525 | 521 | 503 | 502 | 503 | |||||
Stockholders Equity Inclu… | |||||||||||||||
Common Stock Value | 11 | 11 | 10 | 10 | 8 | 8 | 8 | 8 | 7 | 7 | |||||
Additional Paid In Capital | 1,442 | 1,440 | 1,382 | 1,380 | 1,287 | 1,284 | 1,282 | 1,279 | 1,181 | 1,181 | |||||
Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -1 | -1 | -0 | -1 | -1 | 0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -1,669 | -1,636 | -1,630 | -1,589 | -1,532 | -1,493 | -1,463 | -1,419 | -1,382 | -1,335 | |||||
Stockholders Equity | -216 | -186 | -238 | -199 | -238 | -203 | -172 | -132 | -194 | -148 | |||||
Liabilities And Stockholders Equity | 291 | 323 | 290 | 322 | 273 | 322 | 349 | 372 | 308 | 355 | |||||
Common Stock Par Or Stated Value Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |||||
Common Stock Shares Issued | 130 | 128 | 115 | 115 | 102 | 102 | 99 | 99 | 89 | 89 | |||||
Shares Outstanding | 127 | 126 | 113 | 112 | 99 | 99 | 97 | 96 | 83 | 82 | |||||
Treasury Stock Common Shares | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 7 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.61% | -72.28% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 102.76% | 57.46% | 48.62% | 20.41% | 38.78% | 51.70% | -21.85% | -16.39% | -14.25% | -21.25% | -20.21% | -29.17% |
| 2024 | -22.92% | -28.99% | -18.43% | -0.68% | 5.48% | 1.03% | -17.41% | -30.72% | -39.59% | -20.39% | 24.34% | 135.53% |
| 2023 | - | - | - | - | - | - | - | - | - | 28.21% | 25.64% | -12.05% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data